
A portal to another world – Automated cell engineering in drug discovery
Tuesday, October 21, 2025
To better suit your schedule and time zone, this webinar will be offered in two separate sessions:
Session 1 broadcasting at 09:00 BST | 10:00 CEST
Session 2 broadcasting at 13:00 EDT | 10:00 PDT
Efficient delivery of biomolecules such as small molecules, proteins, peptides, and intracellular assays remains a critical challenge to both cell engineering and drug discovery across scales. While electroporation is widely used, it has high costs, low cell survival rates, and labor-intensive workflows. Mechanoporation offers a promising alternative, though traditional implementations have struggled to achieve scalability.
Join Dr. Armon Sharei, Portal Bio, and Dennis Condy, Eppendorf, as they discuss how the integration of advanced mechanoporation technology with automated liquid handling enables a cost-effective, high-throughput solution for next-generation cell engineering and drug screening workflows, while also maintaining reproducibility across experiments for greater confidence in results.
Who should attend?
- Discovery and R&D groups across drug discovery and cell therapy
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Speakers



What will this webinar cover?
- Uncover how mechanoporation opens a whole new galaxy of cargo delivery
- Explore how to leverage automation to go beyond current drug screening and cell engineering workflows
- Discover how to maintain reproducibility whilst boosting your sample throughput
Join the webinar to get answers to these questions:
- How does mechanoporation enable efficient delivery of diverse biomolecular cargo?
- In what ways can automation enhance drug screening and cell engineering workflows?
- How does this approach compare with traditional electroporation in cost and cell viability?
- What strategies help maintain reproducibility while increasing sample throughput?
- How can these technologies be scaled for discovery, R&D, and cell therapy applications?


